MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s12879-021-06821-1

Медицинская библиотека · BMC infectious diseases · 2021

Inadequate use of antibiotics in the covid-19 era: effectiveness of antibiotic therapy.

Bendala Estrada Alejandro David, Calderón Parra Jorge, Fernández Carracedo Eduardo, Muiño Míguez Antonio, Ramos Martínez Antonio, Muñez Rubio Elena, Rubio-Rivas Manuel, Agudo Paloma, Arnalich Fernández Francisco, Estrada Perez Vicente, Taboada Martínez María Luisa, Crestelo Vieitez Anxela, Pesqueira Fontan Paula Maria, Bustamante Marta, Freire Santiago J, Oriol-Bermúdez Isabel, Artero Arturo, Olalla Sierra Julián, Areses Manrique María, Carrasco-Sánchez H Francisco Javier, Vento Vanessa Carolina, García García Gema María, Cubero-Morais Pablo, Casas-Rojo José-Manuel, Núñez-Cortés Jesús Millán

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Since December 2019, the COVID-19 pandemic has changed the concept of medicine. This work aims to analyze the use of antibiotics in patients admitted to the hospital due to SARS-CoV-2 infection.

METHODS

This work analyzes the use and effectiveness of antibiotics in hospitalized patients with COVID-19 based on data from the SEMI-COVID-19 registry, an initiative to generate knowledge about this disease using data from electronic medical records. Our primary endpoint was all-cause in-hospital mortality according to antibiotic use. The secondary endpoint was the effect of macrolides on mortality.

RESULTS

Of 13,932 patients, antibiotics were used in 12,238. The overall death rate was 20.7% and higher among those taking antibiotics (87.8%). Higher mortality was observed with use of all antibiotics (OR 1.40, 95% CI 1.21-1.62; p < .001) except macrolides, which had a higher survival rate (OR 0.70, 95% CI 0.64-0.76; p < .001). The decision to start antibiotics was influenced by presence of increased inflammatory markers and any kind of infiltrate on an x-ray. Patients receiving antibiotics required respiratory support and were transferred to intensive care units more often.

CONCLUSIONS

Bacterial co-infection was uncommon among COVID-19 patients, yet use of antibiotics was high. There is insufficient evidence to support widespread use of empiric antibiotics in these patients. Most may not require empiric treatment and if they do, there is promising evidence regarding azithromycin as a potential COVID-19 treatment.

Для цитирования: Bendala Estrada Alejandro David, Calderón Parra Jorge, Fernández Carracedo Eduardo, Muiño Míguez Antonio, Ramos Martínez Antonio, Muñez Rubio Elena, Rubio-Rivas Manuel, Agudo Paloma, Arnalich Fernández Francisco, Estrada Perez Vicente, Taboada Martínez María Luisa, Crestelo Vieitez Anxela, Pesqueira Fontan Paula Maria, Bustamante Marta, Freire Santiago J, Oriol-Bermúdez Isabel, Artero Arturo, Olalla Sierra Julián, Areses Manrique María, Carrasco-Sánchez H Francisco Javier, Vento Vanessa Carolina, García García Gema María, Cubero-Morais Pablo, Casas-Rojo José-Manuel, Núñez-Cortés Jesús Millán. Inadequate use of antibiotics in the covid-19 era: effectiveness of antibiotic therapy.. BMC infectious diseases. 2021. DOI: 10.1186/s12879-021-06821-1.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.